Phibro Animal Health (PAHC) Misses Q4 EPS by 2c, Revenues Beat

Phibro Animal Health (NASDAQ: PAHC) reported Q4 EPS of $0.36, $0.02 worse than the analyst estimate of $0.38. Revenue for the quarter came in at $255.3 million versus the consensus estimate of $250.04 million.

GUIDANCE:

Phibro Animal Health sees FY 2023 revenue of $0.96-1 billion, versus the consensus of $910.21 million.

For earnings history and earnings-related data on Phibro Animal Health (PAHC) click here.

You May Also Be Interested In

• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
• William Blair Upgrades Backblaze Inc (BLZE) to Market Perform
• BofA lists top 5 themes driving next $1tn in incremental semi sales